Krystal Biotech announces dosing of first patient in Phase 3 trial evaluating KB803 for corneal abrasions in DEB patients.

Krystal Biotech announced the first patient has been dosed in EMERALD-1, its phase 1/2 clinical trial evaluating KB801 for ...

Repeat administration under compassionate use was previously shown to be well tolerated and associated with full corneal healing by 3 months as well as significant visual acuity improvement from ...

Krystal Biotech Announces First Patient Dosed in Phase 3 Clinical Trial of KB803 for the Treatment and Prevention of Corneal Abrasions in Patients with Dystrophic ...

Pinhole Pupilloplasty offers a simple, low-cost alternative to corneal transplants, providing clear vision with minimal complications.

KB803 is a redosable, eye drop gene therapy designed to deliver two copies of the COL7A1 transgene to the epithelial cells in a patient's eye for the treatment and prevention of corneal abrasions ...

Krystal Biotech climbs after dosing begins in a phase I/II trial for KB801, a gene therapy eye drop targeting neurotrophic keratitis.

"I congratulate the government and people of Burundi and commend them for their hard work and dedication. The elimination of ...

How to manage an acute case of Bell’s palsy in a pregnant woman including the importance of prompt treatment and when ...

Anthony Davis, Dallas Mavericks star, underwent eye surgery. This followed an injury-filled season. Davis joined the ...

Doctors describe some of the most common injuries caused by fireworks — and how to prevent them without missing out on the fun.

Some folks collect stamps. The post Mavs Announce Major Anthony Davis Injury Update After Cooper Flagg’s Revelation appeared first on EssentiallySports.